FUJIFILM Irvine Scientific will sell its Medical Media Business Unit to Astorg, a leading European private equity firm.
The deal, expected to close on April 1, 2025, will integrate the MBU into Astorg’s growing MedTech platform, which recently added Hamilton Thorne and Cook Medical’s Reproductive Health business.
The MBU, part of FUJIFILM Irvine Scientific’s Life Sciences Business Division, focuses on IVF, infertility research, and cytogenetic analysis. The sale allows FUJIFILM Irvine Scientific to concentrate on its core life sciences operations, driving innovation and accessibility in cell culture solutions for medical and research applications.
Astorg plans to leverage the MBU’s expertise to enhance its presence in the assisted reproductive technology (ART) and IVF sectors. The transition is expected to complete by January 2026, ensuring continuity for current customers and partners.
This acquisition underscores Astorg’s commitment to advancing healthcare solutions and expanding its global MedTech footprint. For FUJIFILM Irvine Scientific, the move aligns with its mission to enrich lives through innovative therapies and solutions.
Source: Private Equity Wire
Can’t stop reading? Read more
HarbourVest teams up with CAIA to boost investor expertise in private markets
HarbourVest teams up with CAIA to boost investor expertise in private markets HarbourVest has...
Boyu takes control of Starbucks China in 20,000-store expansion push
Boyu takes control of Starbucks China in 20,000-store expansion push Boyu Capital has completed...
Apollo exits $14.2bn Intel fab stake as strategic partnership evolves
Apollo exits $14.2bn Intel fab stake as strategic partnership evolves Apollo has agreed to sell...